NCT00940641View on ClinicalTrials.gov

Assess the Absorption, Distribution, Metabolism and Excretion of AZD7325 After Intravenous and Oral Administration

PHASE1SuspendedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

August 31, 2009

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions
AbsorptionDistributionMetabolismExcretion
Interventions
DRUG

AZD7325

IV Dose

DRUG

AZD7325

oral dose

Trial Locations (1)

Unknown

Research Site, Alderley Park

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY